TRANMEP Drug Patent Profile
When do Tranmep patents expire, and when can generic versions of Tranmep launch?
Tranmep is a drug marketed by Solvay and is included in two NDAs.
The generic ingredient in TRANMEP is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tranmep
A generic version of TRANMEP was approved as meprobamate by INVAGEN PHARMS on February 27th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRANMEP?
- What are the global sales for TRANMEP?
- What is Average Wholesale Price for TRANMEP?
Summary for TRANMEP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 4,565 |
| DailyMed Link: | TRANMEP at DailyMed |
US Patents and Regulatory Information for TRANMEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | TRANMEP | meprobamate | TABLET;ORAL | 084369-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | TRANMEP | meprobamate | TABLET;ORAL | 016249-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
